301096 Stock Overview
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥39.96 |
| 52 Week High | CN¥77.78 |
| 52 Week Low | CN¥33.57 |
| Beta | 0.31 |
| 11 Month Change | -2.30% |
| 3 Month Change | 8.53% |
| 1 Year Change | -38.05% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -41.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| 301096 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | -3.7% | -4.9% | -2.6% |
| 1Y | -38.0% | -31.6% | 4.2% |
Return vs Industry: 301096 underperformed the CN Life Sciences industry which returned -31.2% over the past year.
Return vs Market: 301096 underperformed the CN Market which returned 4.6% over the past year.
Price Volatility
| 301096 volatility | |
|---|---|
| 301096 Average Weekly Movement | 9.8% |
| Life Sciences Industry Average Movement | 10.5% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 301096 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 301096's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 1,786 | Jinfang Lou | www.hzbio-s.com |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. operates as a pharmaceutical technology research and development and services company in China. The company primarily provides drug research and development services; and the transformation of research and development technology results for various pharmaceutical, as well as pharmaceutical research and development investment companies.
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Fundamentals Summary
| 301096 fundamental statistics | |
|---|---|
| Market cap | CN¥4.33b |
| Earnings (TTM) | CN¥212.13m |
| Revenue (TTM) | CN¥1.03b |
20.4x
P/E Ratio4.2x
P/S RatioIs 301096 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301096 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.03b |
| Cost of Revenue | CN¥399.02m |
| Gross Profit | CN¥626.10m |
| Other Expenses | CN¥413.96m |
| Earnings | CN¥212.13m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.96 |
| Gross Margin | 61.08% |
| Net Profit Margin | 20.69% |
| Debt/Equity Ratio | 21.6% |
How did 301096 perform over the long term?
See historical performance and comparison